Save time and get answers to complex questions with AI chat
Drugpatentwatch crizotinib?Is guselkumab off patent in u s?What's the impact of mixing lipitor bp meds negatively?Pramlintide fda approval date?How often should lurbinectedin's long term effects be monitored?
See the DrugPatentWatch profile for tigecycline
Tigecycline is commonly associated with gastrointestinal (GI) adverse effects. Across clinical studies, the most frequently reported GI events include nausea and vomiting, with diarrhea also occurring.
In trials of tigecycline, GI side effects were among the most frequent reasons for treatment interruption and included: - Nausea - Vomiting - Diarrhea
Rates vary by indication and study design, but GI adverse events (especially nausea and vomiting) are frequent enough to be considered class-label risks for tigecycline.
For the precise “frequency” numbers (overall incidence and by event type) you can check the adverse-reaction table in the prescribing information for tigecycline (or a label summary site that reproduces it). If you share which tigecycline label you’re looking at (for example, a specific country’s SmPC/label or a particular trial context), I can help you locate the exact incidence figures.
Other Questions About Tigecycline :